Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-24 @ 3:04 PM
NCT ID:
NCT02158559
Eligibility Criteria:
Inclusion Criteria:
* Clinically definite or laboratory-supported diagnosis of STEMI ,with the indication of PTCA surgery.
* 18≤Age≤75;
* Agreed to join in the study and signed the inform consent form.
Exclusion Criteria:
* Cardiogenic shock , Killip III-IV degree , papillary muscle rupture , septal perforation , episodes of ventricular tachycardia and ventricular fibrillation after electrical cardioversion , temporary pacemaker implanted AVB III degree.
* Past history of PCI and CABG
* Acute or chronic infectious diseases(for example severe pneumonia);
* Recent history of hemorrhagic stroke(within six months)
* Combined with liver and kidney dysfunction;
* History of valvular heart disease;
* Congenital heart disease or Pulmonary hypertension;
* All kinds of history of cardiomyopathy;
* Bleeding and other thrombotic diseases;
* Severe anemia , thrombocytopenia , Other diseases of the blood system;
* Cancer , Autoimmune disease , All kinds of the patients who use the glucocorticoid and immunosuppressor;
* Menstrual period women, pregnant women and lactating women, pregnancy test positive or recent family planning.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02158559
Study Brief:
Protocol Section:
NCT02158559